A STUDY ON THE VARIATION IN THE COST OF ORAL HYPOGLYCEMIC AGENTS IN INDIAN PHARMACEUTICAL MARKET
Author(s)
Vk S1, Tiwari P2
1SAS NAGAR, PUNJAB, India, 2National Institute of Pharmaceutical Education and Research, Mohali, India
Presentation Documents
OBJECTIVES: To analyze the variation in the cost of single drug formulations (SDFs) as well as fixed-dose combinations (FDCs) of oral hypoglycemic agents (OHAs) in Indian pharmaceutical market. METHODS: A screening for the SDFs as well as FDCs of OHAs was performed using online version of Current Index of Medical Specialties (CIMS) and Drug Today (Volume 2, July-September 2016). The cost of 10 units of tablets or capsules in Indian rupee (INR) of SDFs and FDCs of all brands were captured. Some FDCs of OHAs were excluded because APIs of FDCs were not available as an individual formulation in the market or costs were not available in the latest edition of Drug Today and CIMS. Percentage cost variation and average cost of SDFs and FDCs were calculated and compared. RESULTS:
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PDB35
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Diabetes/Endocrine/Metabolic Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now